Alterations of The Stem-Like Properties in The Breast Cancer Cell Line MDA-MB-231 Induced by Single Pulsed Doxorubicin Treatment

Achuthan, S., Santhoshkumar, T. R., Prabhakar, J., Nair, S. A., Pillai, M. R. (2011). Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species. J. Biol. Chem., 286 (43), 37813–37829.10.1074/jbc.M110.200675Search in Google Scholar

Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA,100 (7), 3983–3988.10.1073/pnas.0530291100Search in Google Scholar

Anonymous (2018). R: A Language and Environment for Statistical Computing. R foundation for statistical computing, Vienna. Available from: https://www.R-project.org/ (accessed 20.01.2019).Search in Google Scholar

Brooks, D. L. P., Schwab, L. P., Krutilina, R., Parke, D. N., Sethuraman, A., Hoogewijs, D., Schörg, A., Gotwald, L., Fan, M., Wenger, R. H., Seagroves, T. N. (2016). ITGA6 is directly regulated by hypoxia- inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models. Mol. Cancer, 15, 26.10.1186/s12943-016-0510-xSearch in Google Scholar

Cortós-Funes, H., Coronado, C. (2007). Role of anthracyclines in the era of targeted therapy. Cardiovasc. Toxicol.,7 (2), 56–60.10.1007/s12012-007-0015-3Search in Google Scholar

Cox, J., Weinman, S. (2016). Mechanisms of doxorubicin resistance in hepatocellular carcinoma. Hepat Oncol.,3 (1), 57–59.10.2217/hep.15.41Search in Google Scholar

Dasari, S., Tchounwou, P. B. (2014). Cisplatin in cancer therapy: Molecular mechanisms of action. Eur. J. Pharmacol.,740, 364–378.10.1016/j.ejphar.2014.07.025Search in Google Scholar

Dean, M., Fojo, T., Bates, S. (2005). Tumour stem cells and drug resistance. Nat. Rev. Cancer, 5 (4), 275–284.10.1038/nrc1590Search in Google Scholar

Dean, M., Hamon, Y., Chimini, G. (2001). The human ATP-binding cassette transporter superfamily. J. Lipid Res.,42 (7), 1007–1017.10.1016/S0022-2275(20)31588-1Search in Google Scholar

Deng, X., Apple, S., Zhao, H., Song, J., Lee, M., Luo, W., Wu, X., Chung, D., Pietras, R. J., Chang, H. R. (2017) CD24 expression and differential resistance to chemotherapy in triple-negative breast cancer. Oncotarget,8 (24), 38294–38308.10.18632/oncotarget.16203550353328418843Search in Google Scholar

El-Badawy, A., Ghoneim, M. A., Gabr, M. M., Salah, R. A., Mohamed, I. K., Amer, M., El-Badri, N. (2017). Cancer cell-soluble factors reprogram mesenchymal stromal cells to slow cycling, chemoresistant cells with a more stem-like state. Stem Cell Res. Ther., 8 (1), 254.10.1186/s13287-017-0709-9568880329115987Search in Google Scholar

Erenpreisa, J., Ivanov, A., Wheatley, S. P., Kosmacek, E. A., Ianzini, F., Anisimov, A. P., Mackey, M., Davis, P. J., Illidge, T. M. (2008). Endopolyploidy in irradiated p53-deficient tumour cell lines: Persistence of cell division activity in giant cells expressing Aurora-B kinase. Cell Biol. Int.,32 (9), 1044–1056.10.1016/j.cellbi.2008.06.003Search in Google Scholar

Fei, F., Zhang, D., Yang, Z., Wang, S., Wang, X., Wu, Z., Wu, Q., Zhang, S. (2015). The number of polyploid giant cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis un human breast cancer. J. Exp. Clin. Cancer Res.,34, 158.Search in Google Scholar

Freshney, R. I. (2011). Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications. Hoboken, NY.: Wiley-Blackwell. 728 pp.Search in Google Scholar

Gewirtz, D. A. (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol.,57 (7), 727–741.10.1016/S0006-2952(98)00307-4Search in Google Scholar

Gottesman, M. M., Fojo, T., Bates, S. E. (2002). Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat. Rev. Cancer,2 (1), 48–58.10.1038/nrc70611902585Search in Google Scholar

Hafner, M., Niepel, M., Chung, M., Sorger, P. K. (2016). Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs. Nat. Methods, 13 (6), 521–527.10.1038/nmeth.3853488733627135972Search in Google Scholar

Hafner, M., Niepel, M., Sorger, P. K. (2017). Alternative drug sensitivity metrics improve preclinical cancer pharmacogenomics. Nat. Biotechnol.,35 (6), 52–54.10.1038/nbt.3882566813528591115Search in Google Scholar

Holohan, C., Van Schaeybroeck, S., Longley, D. B., Johnston, P. G. (2013). Cancer drug resistance: An evolving paradigm. Nat. Rev. Cancer, 13 (10), 714–726.10.1038/nrc359924060863Search in Google Scholar

Hu, H., Wang, M., Guan, X., Yuan, Z., Liu, Z., Zou, C., Guiyu, W., Gao, X., Wang, X. (2018). Loss of ABCB4 attenuates the caspase-dependent apoptosis regulating resistance to 5-Fu in colorectal cancer. Biosci Rep.,38 (1), BSR20171428.10.1042/BSR20171428582194329371412Search in Google Scholar

Huang, Z. J., You, J., Luo, W. Y., Chen, B. S., Feng, Q. Z., Wu, B. L., Jiang, L., Luo, Q. (2015). Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells. Mol. Med. Rep.,11 (3), 1647–1654.10.3892/mmr.2014.2972427031925405855Search in Google Scholar

Hwang-Verslues, W. W., Kuo, W. H., Chang, P. H., Pan, C. C., Wang, H. H., Tsai, S. T., Jeng, Y. M., Shew, J. Y., Kung, J. T., Chen, C. H., Lee, E. Y., Chang, K. J., Lee, W. H. (2009). Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PLoS ONE, 4 (12), e8377.10.1371/journal.pone.0008377279343120027313Search in Google Scholar

Jia, D., Tan, Y., Liu, H., Ooi, S., Li, L., Wright, K., Bennett, S., Addison, C.L., Wang, L. (2016). Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo. Oncotarget,7 (1), 771–785.10.18632/oncotarget.5819480803226506421Search in Google Scholar

Kibria, G., Hatakeyama, H., Akiyama, K., Hida, K., Harashima, H. (2014). Comparative study of the sensitivities of cancer cells to doxorubicin, and relationships between the effect of the drug-efflux pump P-gp. Biol. Pharm. Bull., 37 (12), 1926–1935.10.1248/bpb.b14-0052925451842Search in Google Scholar

Kim, W., Ryu, C. J. (2017). Cancer stem cell surface markers on normal stem cells. BMB Rep.,50 (6), 285–298.10.5483/BMBRep.2017.50.6.039549813928270302Search in Google Scholar

Leggett, S. E., Sim, J. Y., Rubins, J. E., Neronha, Z. J., Williams, K., Wong, I. Y. (2016). Morphological single cell profiling of the epithelial-mesenchymal transition. Integr. Biol. (Camb).,8 (11), 1133–1144.10.1039/C6IB00139D541736227722556Search in Google Scholar

Liang, Y., Zhong, Z., Huang, Y., Deng, W., Cao, J., Tsao, G., Liu, Q., Pei, D., Kang, T., Zeng, Y.X. (2010). Stem-like cancer cells are inducible by increasing genomic instability in cancer cells. J. Biol. Chem., 285 (7), 4931–4940.10.1074/jbc.M109.048397283609720007324Search in Google Scholar

Ling, G. Q., Chen, D. B., Wang, B. Q., Zhang, L. S. (2012). Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell lines. Oncol. Lett.,4 (6), 1264–1268.10.3892/ol.2012.916350671723197999Search in Google Scholar

Liu, P., Kumar, I. S., Brown, S., Kannappan, V., Tawari, P. E., Tang, J. Z., Jiang, W., Armesilla, A. L., Darling, J. L., Wang, W. (2013). Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells. Brit. J. Cancer, 109 (7), 1876–1885.10.1038/bjc.2013.534379018424008666Search in Google Scholar

Livak, K. J., Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods, 25 (4), 402–408.Search in Google Scholar

McDermott, M., Eustace, A. J., Busschots, S., Breen, L., Crown, J., Clynes, M., O’Donovan N., Stordal, B. (2014). In vitro development of chemotherapy and targeted therapy drug-resistant cancer cell lines: A practical guide with case studies. Front. Oncol., 4, 40.10.3389/fonc.2014.00040394478824639951Search in Google Scholar

Mckenna, M. T., Weis, J. A., Barnes, S. L., Tyson, D. R., Miga, I., Quaranta, V., Yankeelov, T. E. (2017). Modeling approach for the study of doxorubicin treatment in triple negative breast cancer. Sc. Rep., 7 (1), 5725.Search in Google Scholar

Mirzayans, R., Andrais, B., Murray, D. (2018). Roles of polyploid/multinucleated giant cancer cells in metastasis and disease relapse following anticancer treatment. Cancers,10, 118.10.3390/cancers10040118592337329662021Search in Google Scholar

Moitra, K., Lou, H., Dean, M. (2011). Multidrug efflux pumps and cancer stem cells: Insights into multidrug resistance and therapeutic development. Clin. Pharmacol. Ther., 89 (4), 491–502.10.1038/clpt.2011.1421368752Search in Google Scholar

Niu, N., Zhang, J., Zhang, N., Mercado-Uribe, I., Tao, F., Han, Z., Pathak, S., Multani, A. S., Kuang, J., Yao, J., Bast, R.C., Sood, A.K., Hung, M.-C., Liu, J. (2016). Linking genomic reorganization to tumor initiation via the giant cell cycle. Oncogenesis,5, e281.10.1038/oncsis.2016.75517777327991913Search in Google Scholar

Nowell, P. C. (1976). The clonal evolution of tumor cell populations. Science, 194 (4260), 23–28.Search in Google Scholar

Rajaraman, R., Guernsey, D. L., Rajaraman, M. M., Rajaraman, S. R. (2006). Stem cells, senescence, neosis and self-renewal in cancer. Cancer Cell Int., 6, 1–26.10.1186/1475-2867-6-25166458517092342Search in Google Scholar

Rivera, E., Gomez, H. (2010). Chemotherapy resistance in metastatic breast cancer: The evolving role of ixabepilone. Breast Cancer Res.,12 (Suppl 2), S2.10.1186/bcr2573297255621050423Search in Google Scholar

Saxena, M., Stephens, M. A., Pathak, H., Rangarajan, A. (2011). Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters. Cell Death Dis., 2, e179.10.1038/cddis.2011.61319972221734725Search in Google Scholar

Sheridan, C., Kishimoto, H., Fuchs, R. K., Mehrotra, S., Bhat-Nakshatri, P., Turner, C. H., Goulet, R. Jr., Badve, S., Nakshatri, H. (2006). CD44+/CD24-Breast cancer cells exhibit enhanced invase properties: An early step necessary for metastasis. Breast Cancer Res., 8 (5), R59.10.1186/bcr1610177949917062128Search in Google Scholar

Skehan, P., Storeng, R., Scudiero, D., Monks, A., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., Boyd, M. R. (1990). New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst.,82 (13), 1107–1112.10.1093/jnci/82.13.11072359136Search in Google Scholar

Smith, L. Watson, M. B., O’Kane, S. L., Drew, P. J., Lind, M. J., Cawkwell, L. (2006). The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays. Mol. Cancer Ther.,5 (8), 2115–2120.10.1158/1535-7163.MCT-06-019016928833Search in Google Scholar

Sun, L., Cabarcas, S. M., Farrar, W. L. (2012). Radioresistance and cancer stem cells: Survival of the fittest. J. Carcinogene Mutagenes, s1(01), 1–12.Search in Google Scholar

Sundaram, M., Guernsey, D. L., Rajaraman, M. M., Rajaraman, R. (2004). Neosis: A novel type of cell division in cancer. Cancer Biol. Ther.,3, 2017–2218.10.4161/cbt.3.2.66314726689Search in Google Scholar

Tegze, B., Szállási, Z., Haltrich, I., Pénzváltó, Z., Tóth, Z., Likó, I., Gyorffy, B. (2012). Parallel evolution under chemotherapy pressure in 29 breast cancer cell lines results in dissimilar mechanisms of resistance. PLoS ONE, 7 (2), 1–9.10.1371/journal.pone.0030804327108922319589Search in Google Scholar

Vassilopoulos, A., Chisholm, C., Lahusen, T., Zheng, H., Deng, C. (2013). A critical role of CD29 and CD49f in mediating metastasis for cancer-initiating cells isolated from a Brca1-associated mouse model of breast cancer. Oncogene,33 (47), 5477–5482.Search in Google Scholar

Vichai, V., Kirtikara, K. (2006). Sulforhodamine B colorimetric assay for cytotoxicity screening. Nature Protocols, 1 (3), 1112–1116.10.1038/nprot.2006.17917406391Search in Google Scholar

Vinogradov, S., Wei, X. (2012). Cancer stem cells and drug resistance: The potential of nanomedicine. Nanomedicine (Lond)., 7 (4), 597–615.10.2217/nnm.12.22337609022471722Search in Google Scholar

Wang, L., Li, P., Hu, W., Xia, Y., Hu, C., Liu, L., Jiang, X. (2017). CD44 + CD24 + subset of PANC-1 cells exhibits radiation resistance via decreased levels of reactive oxygen species. Oncol. Lett.,14 (2), 1341–1346.10.3892/ol.2017.6301552979828789349Search in Google Scholar

Weihua, Z., Lin, Q., Ramoth, A. J., Fan, D., Fidler, I. J. (2011). Formation of solid tumors by a single multinucleated cancer cell. Cancer,117 (17), 4092–4099.10.1002/cncr.26021313661321365635Search in Google Scholar

Xiang, D., Shigdar, S., Bean, A. G., Bruce, M., Yang, W., Mathesh, M., Wang, T., Yin, W., Tran, P. H., Al Shamaileh, H., Barrero, R. A., Zhang, P. Z., Li, Y., Kong, L., Liu, K., Zhou, S. F., Hou, Y., He, A., Duan, W. (2017). Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery. Theranostics., 7 (17), 4071–4086.10.7150/thno.20168569499829158811Search in Google Scholar

Zhang, S., Mercado-Uribe, I., Xing, Z., Sun, B., Kuang, J., Liu, J. (2014). Generation of cancer stem-like cells through the formation of polyploid giant cancer cells. Oncogene, 33 (1), 116–128.Search in Google Scholar